Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms-Reference-Cited by-同舟云学术

Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms

Published:2022-10 Issue: Volume:184 Page:106416
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Dai Hao-Ran,Liu Yun,Lu Ke-Yu,He Xin,Guo Hong-Li,Hu Ya-Hui,Xu Jing,Ding Xuan-Sheng,Chen Feng,Cheng Rui,Jiao Zheng

Publisher

Elsevier BV

Subject

Pharmacology

Reference83 articles.

1. Apnea of prematurity;Eichenwald;Pediatrics,2016

2. Apnoea of prematurity and neurodevelopmental outcomes: current understanding and future prospects for research;Williamson;Front Pedia,2021

3. Therapy for apnoea of prematurity: a retrospective study on effects of standard dose and genetic variability on clinical response to caffeine citrate in chinese preterm infants;He;Adv. Ther.,2021

4. Caffeine for the pharmacological treatment of apnea of prematurity in the NICU: dose selection conundrum, therapeutic drug monitoring and genetic factors;Long;Front. Pharmacol.,2021

5. The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies;Henderson-Smart;Aust. Paediatr. J.,1981

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models;European Journal of Pharmaceutics and Biopharmaceutics;2024-11

2. Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infants;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27

3. Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future;Advanced Drug Delivery Reviews;2024-08

4. From “wet” matrices to “dry” blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infants;Clinical Chemistry and Laboratory Medicine (CCLM);2023-07-13

5. Efficacy and Safety Evaluation of Different Maintenance Dose Regimens of Caffeine Citrate in the Treatment of Primary Apnea in Preterm Infants;CURRENT TOPICS IN NUTRACEUTICAL RESEARCH;2023-07-07